Citation Impact
Citing Papers
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Inadequate Antimicrobial Treatment of Infections
1999 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
A simulation study of the number of events per variable in logistic regression analysis
1996 Standout
Phototherapy for Neonatal Jaundice
2008 Standout
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A meta-analysis of stages I and II Hodgkin's disease
1990
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Circos: An information aesthetic for comparative genomics
2009 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Consensus-based method for risk adjustment for surgery for congenital heart disease
2002 Standout
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
2012 Standout
Complications of Endoscopic Biliary Sphincterotomy
1996 Standout
A New Casemix Adjustment Index for Hospital Mortality Among Patients With Congestive Heart Failure
1998
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)
2004
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Co-expression of Epstein-Barr virus latent membrane protein and vimentin in “aggressive” histological subtypes of Hodgkin's disease
1993
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Laboratory Evaluation of Jaundice in Newborns
1990
Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns
1999 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
8 Malignant lymphoma in the elderly
1987
Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.
2003
Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study.
2010 Standout
The Contribution of Hemolysis to Early Jaundice in Normal Newborns
2006
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors
2000
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
2005 Standout
The Risk of Determining Risk with Multivariable Models
1993 Standout
Activation of stratospheric chlorine by reactions in liquid sulphuric acid
1994 StandoutNobel
Bone Marrow Transplant
1990 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas
1987
Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy
2014
Bilirubin Metabolism and Kernicterus
1997
Hodgkin's lymphoma
2003
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Works of M.J. Easterling being referenced
Case-mix adjustment using objective measures of severity: the case for laboratory data.
1994
Improving the homogeneity of diagnosis-related groups (DRGs) by using clinical laboratory, demographic, and discharge data.
1989
Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients
1989
The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: An analysis of 271 non-laparotomised cases (BNLI report no. 22)
1983
Systemic disturbance in Hodgkin's disease and its relation to histopathology and prognosis (BNLI report No. 30)
1987
REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX
1985
The prognostic significance of age in Hodgkin's disease: Examination of 1500 patients (BNLI report no. 23)
1983
Yield of Reticulocyte Counts and Blood Smears in Term Infants
1994